INTERNATIONAL BIOTECHNOLOGY TRUST PLC - AMICUS THERAPEUTICS INC ownership

AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 226 filers reported holding AMICUS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.62 and the average weighting 0.3%.

Quarter-by-quarter ownership
INTERNATIONAL BIOTECHNOLOGY TRUST PLC ownership history of AMICUS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,092,600
-98.8%
90,000
+8749.6%
0.37%
-62.7%
Q2 2022$94,600,000
+8547.2%
1,017
-98.9%
0.99%
+299.6%
Q1 2022$1,094,0000.0%94,6000.0%0.25%
+1.2%
Q4 2021$1,094,000
+21.0%
94,6000.0%0.24%
+11.9%
Q3 2021$904,000
-0.9%
94,6000.0%0.22%
-9.5%
Q2 2021$912,000
-2.5%
94,6000.0%0.24%
-2.4%
Q1 2021$935,000
-57.2%
94,6000.0%0.25%
-58.6%
Q4 2020$2,185,000
+63.5%
94,6000.0%0.60%
+38.5%
Q3 2020$1,336,000
-9.1%
94,6000.0%0.43%
-11.9%
Q2 2020$1,470,000
+68.4%
94,6000.0%0.49%
+22.9%
Q1 2020$873,000
-5.1%
94,6000.0%0.40%
+20.2%
Q4 2019$920,000
+95.7%
94,600
+61.4%
0.33%
+52.5%
Q3 2019$470,000
-35.6%
58,6000.0%0.22%
-19.9%
Q2 2019$730,000
-8.3%
58,6000.0%0.27%
-7.8%
Q1 2019$796,000
+80.9%
58,6000.0%0.29%
+7.7%
Q4 2018$440,000
-19.0%
58,6000.0%0.27%
+5.8%
Q3 2018$543,000
-40.7%
58,6000.0%0.26%
-26.5%
Q2 2018$915,000
+3.9%
58,6000.0%0.35%
+2.0%
Q1 2018$881,000
+4.5%
58,6000.0%0.34%
+15.8%
Q4 2017$843,000
-4.5%
58,6000.0%0.30%
-13.7%
Q3 2017$883,000
+223.4%
58,600
+6.5%
0.34%
+179.7%
Q4 2016$273,00055,0000.12%
Other shareholders
AMICUS THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Palo Alto Investors LP 10,524,022$127,972,10812.11%
Perceptive Advisors 27,692,917$336,745,87011.23%
Redmile Group, LLC 16,944,621$206,046,5919.80%
Finepoint Capital LP 1,489,025$18,106,5449.02%
CM Management, LLC 450,000$5,472,0005.81%
Avoro Capital Advisors LLC 27,400,000$333,184,0005.20%
MPM BioImpact LLC 716,139$8,708,2502.32%
Artal Group S.A. 4,062,567$49,4012.12%
SECTORAL ASSET MANAGEMENT INC 803,464$9,770,1221.90%
GREAT POINT PARTNERS LLC 857,000$10,421,1201.90%
View complete list of AMICUS THERAPEUTICS INC shareholders